Case Report of Fibrocartilaginous Embolic Myelopathy of the Spinal Cord in a Female Dog
Article Sidebar
PDF downloads: 90
XML-Crossref downloads: 4
Crossref Citations: 0
Main Article Content
Abstract
Introduction: Fibrocartilaginous embolic Myelopathy is a non-progressive injury in the spinal cord that can cause infarction in the veins of spinal parenchyma, leading to ischemia and necrosis.
Case report: Fibrocartilaginous embolic Myelopathy was diagnosed in a 4-year-old female Spitz dog using the clinical neurological examination. The dog was hospitalized, and the treatment, including supportive treatment and Cortone, was set up for 3 weeks. Then, Diazepam and Methocarbamol were added to the prescription, and treatment continued for 2 weeks. A general improvement was noted after 3 weeks, and the dog could stand perfectly after 5 weeks.
Conclusion: Three weeks of supportive treatment, Cortone therapy as well as the addition of Diazepam and Methocarbamol to the treatment could help the dog stand on its feet. However, it cannot be ignored that knowing about the history of the dog played an important role in its treatment procedure.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
de Lahunta A, Glass E, Kent M. Veterinary neuroanatomy and clinical neurology.4th ed. St. Louis: Saunders. 2015; p. 268-262. Available at: https://www.elsevier.com/books/veterinary-neuroanatomy-and-clinical-neurology/de-lahunta/978-1-4557-4856-3
Nelson RW, Couto CG. Neuromuscular Disorders. Small Animal Internal Medicine. 5 ed. St. Louis: Mosby: 2019; p. 1059-1060.
Ettinger S, Feldman E, Cote E. Veterinary Internal Medicine,
Elsevier, 8th ed. 2017; p. 3478-3481. Available at: https://www.elsevier.com/books/textbook-of-veterinary-internal-medicine-expert-consult/ettinger/978-1-4557-3633-1
Cauznille L, Kornegay JN. Fibrocartilaginous embolism of the spinal cord in dogs: Review of 36 histologically confirmed cases and retrospective study of 26 suspected cases. J Vet Intern Med. 1996; 10: 241-245. Available at: https://pubmed.ncbi.nlm.nih.gov/8819049/
Sarchahi AA. Neurological examination and nervous system disorders of small animals, 2nd ed. 2016; p. 353-355.
Smith PM, Jeffrey ND. Spinal shock-comparative aspects and clinical relevance. J Vet Intern Med. 2005; 19: 788-793. Available at: https://pubmed.ncbi.nlm.nih.gov/16355670/
de Lahunta A, Alexander JW. Ischemic myelopathy secondary to presumed fibrocartilaginous embolism in nine dogs. J Am Anim Hosp Assoc. 1976; 12: 37. Available at: https://agris.fao.org/agris-search/search.do?recordID=US19770151858
Simpson RK, Robertson CS, Goodman JC. Glycine: An important potential component of spinal shock. Neurochem Res. 1993 Aug;
: 887-892. Available at: https://pubmed.ncbi.nlm.nih.gov/8103919/